Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Glycoprotein / GP (Virus) (partial) protein (His tag)

Spezies: Ebola Virus, Bundibugyo Virus (BDBV) Wirt: HEK-293 Cells Recombinant >95 % as determined by SDS-PAGE. WB
Produktnummer ABIN5608204
  • Target
    Glycoprotein / GP (Virus)
    Protein-Typ
    Recombinant
    Proteineigenschaft
    partial
    Spezies
    • 5
    • 3
    • 1
    • 1
    • 1
    Ebola Virus, Bundibugyo Virus (BDBV)
    Quelle
    • 9
    HEK-293 Cells
    Aufreinigungstag / Konjugat
    His tag
    Applikation
    Western Blotting (WB)
    Sequenz
    Ile 33 - Arg 324
    Reinheit
    >95 % as determined by SDS-PAGE.
    Endotoxin-Niveau
    Endotoxin level is less than 1.0 EU per ug by the LAL method.
  • Applikationshinweise
    This recombinant protein can be used for WB.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Lyophilized Protein should be stored at -20°C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20°C or -70°C.
  • Target
    Glycoprotein / GP (Virus)
    Substanzklasse
    Viral Protein
    Hintergrund
    EBOV encodes seven structural proteins: nucleoprotein (NP), polymerase cofactor (VP35), (VP40), GP, transcription activator (VP30), VP24, and RNA polymerase (L). GP protein contains 160- kDa envelope-attached glycoprotein (GP) and a 110 kDa secreted glycoprotein (sGP). GP is a class I fusion protein which assembles as trimers on viral surface and plays an important role in virus entry and attachment. Mature GP is a disulfide-linked heterodimer formed by two subunits, GP1 and GP2, which are generated from the proteolytical process of GP precursor (pre-GP) by cellular furin during virus assembly . GP1 is responsible for binding to the receptor(s) on target cells. Interacts with CD209/DC-SIGN and CLEC4M/DC-SIGNR which act as cofactors for virus entry into the host cell. GP2 acts as a class I viral fusion protein. GP1,2 mediates endothelial cell activation and decreases endothelial barrier function. sGP seems to possess an anti-inflammatory activity as it can reverse the barrier-decreasing effects of TNF alpha.
    Molekulargewicht
    34.3 kDa
    Gen-ID
    9487265
    UniProt
    B8XCN1
Sie sind hier:
Kundenservice